4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-19-004571
Director bought 3,100 shares at an average $0.69 ($2,131)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HILZINGER KURT J Director | 2019-01-16 | Purchase | +800 | $0.68 | $544 | 112,147 | D: show line 1 in the form |
| HILZINGER KURT J Director | 2019-01-17 | Purchase | +2,300 | $0.69 | $1,587 | 114,447 | D: show line 2 in the form |
| Open-market purchases · 3,100 sh · avg $0.69 · $2,131 | |||||||
Loading xslF345X03/doc4.xml…